par Delabaye, Isabelle;De Keyser, Filip;Badot, Valérie ; [et al.]
Référence Arthritis research & therapy, 12, 3, page (R121)
Publication Publié, 2010
Article révisé par les pairs
Titre:
  • 74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.
Auteur:Delabaye, Isabelle; De Keyser, Filip; Badot, Valérie; et al.
Informations sur la publication:Arthritis research & therapy, 12, 3, page (R121)
Statut de publication:Publié, 2010
Sujet CREF:Médecine pathologie humaine
Rhumatologie
MeSH keywords:Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal -- adverse effects -- therapeutic use
Antirheumatic Agents -- adverse effects -- therapeutic use
Arthritis, Rheumatoid -- drug therapy
Bacterial Infections -- epidemiology
Drug Therapy, Combination
Female
Follow-Up Studies
Health Surveys
Humans
Longitudinal Studies
Male
Methotrexate -- therapeutic use
Middle Aged
Prevalence
Prospective Studies
Treatment Outcome
Tumor Necrosis Factor-alpha -- antagonists & inhibitors
Note générale:Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
REMITRACT study group
Langue:Anglais
Identificateurs:urn:issn:1478-6354
info:doi/10.1186/ar3058
info:pii/ar3058
info:pmid/20569501
PMC2911915